PapersPMID:31398841
Metabolic Effects of Resistant Starch Type 2: A Systematic Literature Review and Meta-Analysis of Randomized Controlled Trials.
- findings
- 5
- compound
- 1
- endpoints
- 5
- Study, every finding
- meta-analysis
- Dose studied, every finding
- 8 to 66 g RS2 per day across trials
No finding here moved its endpoint.
What did not
How to read these marks →“A meta-analysis of all seven studies (n = 406) indicated no significant reduction in LDL cholesterol levels following RS2 supplementation (MD = 0.03 mmol/L; 95% CI −0.10, 0.16, P = 0.66).”
- Participants
- 406
- Effect
- 0.03 mean difference, 95% CI −0.1 to 0.16
- Population
- Healthy individuals and people with the metabolic syndrome or type 2 diabetes, pooled across seven randomized trials
“A meta-analysis of all ten studies (n = 532) indicated no significant change in HDL cholesterol levels following RS2 supplementation in healthy people, those with MetS or individuals with T2DM (MD = −0.01 mmol/L; 95% CI −0.07, 0.04, P = 0.67).”
- Participants
- 532
- Effect
- −0.01 mean difference, 95% CI −0.07 to 0.04
- Population
- Healthy people and people with the metabolic syndrome or type 2 diabetes, pooled across ten randomized trials
“A meta-analysis of all fifteen studies (n = 636) indicated no statistically significant changes in fasting plasma glucose following RS2 supplementation in healthy subjects, subjects with MetS, and subjects with T2DM (MD = −0.03 mmol/L; 95% CI −0.11, 0.05, P = 0.40).”
- Participants
- 636
- Effect
- −0.03 mean difference, 95% CI −0.11 to 0.05
- Population
- Healthy subjects, subjects with the metabolic syndrome (MetS) and subjects with type 2 diabetes, pooled across fifteen randomized trials
“Despite significant reductions in HbA1c observed in two studies undertaken by the same research group, a meta-analysis of all five studies (n = 265) indicated no statistically significant effects of RS2 supplementation on HbA1c in trial participants with prediabetes or T2DM (MD = −0.27%; 95% CI −0.57, 0.03, P = 0.08).”
- Participants
- 265
- Effect
- −0.27 mean difference, 95% CI −0.57 to 0.03
- Population
- Participants with prediabetes or type 2 diabetes, pooled across five randomized trials
“A meta-analysis of all twelve studies (n = 634) investigating the effect of RS2 supplementation on total cholesterol in healthy individuals and those with MetS or T2DM indicated no significant change in total cholesterol (MD = −0.06 mmol/L; 95% CI: −0.15, 0.03, P = 0.18).”
- Participants
- 634
- Effect
- −0.06 mean difference, 95% CI −0.15 to 0.03
- Population
- Healthy individuals and people with the metabolic syndrome or type 2 diabetes, pooled across twelve randomized trials
Study record
- Design
- meta-analysis
- Species
- human
- Population
- Healthy, overweight/obese, metabolic syndrome, prediabetic and type 2 diabetic adults (22 RCTs, 670 participants, aged 23 to 70); resistant starch type 2 at 8 to 66 g/day for 1 to 12 weeks against placebo or control, mostly from high amylose maize starch, one trial native banana starch and one potato starch
- Participants
- 670
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 23